🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alvaro Alvarez Soto

ORCID: 0000-0002-0810-6534

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2 negative metastatic breast cancer”.

Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2 negative metastatic breast cancer

Research Square(2022)10.21203/rs.3.rs-2023753/v1

N/A

0DataRank · unranked

0 citations

Ana M. Bernal, Jesús Anampa, Alvaro Alvarez Soto

Racial disparities in treatment and outcomes between Hispanic and non-Hispanic black women with triple-negative breast cancer

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07565-7

N/A

0DataRank · unranked

1 citations

Alvaro Alvarez Soto, Ana M. Bernal, Ana Acuña-Villaorduña, Jesus Anampa

Adjuvant Chemotherapy in Lymph Node‐Negative, T1 Triple‐Negative Breast Cancer

Cancer Medicine(2025)10.1002/cam4.71347

N/A

0DataRank · unranked

1 citations

Alvaro Alvarez Soto, Rachel Jimenez, Samilia Obeng‐Gyasi, Xiaonan Xue, Jesus Anampa

Use and Benefit of Neoadjuvant Versus Adjuvant Chemotherapy in Node-Negative, T1 Triple Negative Breast Cancer

Clinical Breast Cancer(2025)10.1016/j.clbc.2025.05.011

N/A

0DataRank · unranked

1 citations

Alvaro Alvarez Soto, Shuwen Lin, Ana M. Bernal, Xiaonan Xue, Maja H. Oktay +1 more